Andrew Anglemyer
Overview
Explore the profile of Andrew Anglemyer including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1246
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sua T, Faatoese A, Anglemyer A, Maoate K, Walls T
N Z Med J
. 2025 Feb;
138(1609):45-55.
PMID: 39946568
Aim: To describe the epidemiology and clinical characteristics of acute rheumatic fever (ARF) cases in Canterbury, Aotearoa New Zealand, 2012-2022. Methods: Cases were identified through cross-matching public health notification data,...
2.
Gharpure R, Regan A, Nogareda F, Cheng A, Blyth C, George S, et al.
Lancet Glob Health
. 2025 Jan;
13(2):e203-e211.
PMID: 39890222
Background: Annual estimates of seasonal influenza vaccine effectiveness can guide global risk communication and vaccination strategies to mitigate influenza-associated illness. We aimed to evaluate vaccine effectiveness in countries using the...
3.
Chambers T, Anglemyer A, Chen A, Atkinson J, Elers P, Baker M
Aust N Z J Public Health
. 2024 Nov;
48(6):100197.
PMID: 39500072
Objective: Our primary research objective was to assess the population uptake and contact tracer utilisation of the Bluetooth function of the New Zealand Covid Tracer App (NZCTA) throughout the pandemic....
4.
Ammar S, Anglemyer A, Bennett J, Lees J, Addidle M, Morgan J, et al.
J Infect Public Health
. 2024 Sep;
17(11):102545.
PMID: 39303459
Background: Since October 2022, multiple high-income countries have reported an increase in invasive group A streptococcal (iGAS) infections. This study describes trends in iGAS infections in Aotearoa New Zealand (NZ)...
5.
Burton C, Webb R, Anglemyer A, Humphrey A, Tuatoo A, Best E
Pediatr Infect Dis J
. 2024 Sep;
44(1):90-96.
PMID: 39259857
Background: Increases in childhood invasive pneumococcal disease (IPD) have been reported in several countries following the easing of COVID-19 pandemic mitigations. In Aotearoa New Zealand (AoNZ), a surge in IPD...
6.
Kumbaroff Z, Anglemyer A, Scott J, Duff P, Thirkell C, Walls T
Sex Transm Infect
. 2024 Aug;
100(8):538-539.
PMID: 39209540
No abstract available.
7.
Anglemyer A, Ren X, Gilkison C, Kumbaroff Z, Morgan J, DuBray K, et al.
Lancet Reg Health West Pac
. 2024 May;
46:101082.
PMID: 38745973
Background: In Aotearoa New Zealand (NZ) PCV7 was introduced in 2008, then PCV10 in 2011 and PCV13 in 2014. In 2017 PCV10 was re-introduced, replacing PCV13. In the present study,...
8.
Chambers T, Anglemyer A, Chen A, Baker M
Health Policy
. 2024 Apr;
144:105073.
PMID: 38657315
Background: Digital contact tracing (DCT) aims to improve time-to-isolation (timeliness) and find more potentially exposed individuals (sensitivity) to enhance the utility of contact tracing. The aim of this study was...
9.
Chambers T, Anglemyer A, Chen A, Atkinson J, Baker M
Epidemiol Infect
. 2024 Apr;
152:e66.
PMID: 38629265
This study aimed to understand the population and contact tracer uptake of the quick response (QR)-code-based function of the New Zealand COVID Tracer App (NZCTA) used for digital contact tracing...
10.
Huang Q, Turner N, Wood T, Anglemyer A, McIntyre P, Aminisani N, et al.
Influenza Other Respir Viruses
. 2024 Feb;
18(2):e13247.
PMID: 38350715
Background: New Zealand's (NZ) complete absence of community transmission of influenza and respiratory syncytial virus (RSV) after May 2020, likely due to COVID-19 elimination measures, provided a rare opportunity to...